Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shufeng Jiedu Capsule for Toxic-heat Sepsis
ChiCTR-IPR-16008639Phase 4Recruiting
- Sponsor
- Xinhua Hospital
- Start
- Jun 2016
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in sepsis comparing Shufeng Jiedu Capsule with Placebo (2 arms). Primary endpoint: Sequential Organ Failure Assessment (SOFA). Started Jun 2016; status: recruiting.
02
Drugs
Shufeng Jiedu
03
Conditions
sepsis
Beyond the preview
Go deeper on ChiCTR-IPR-16008639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008639.